Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Lukas Chavez
Affiliation
University of California San Diego
ORCID
Career Start Year
2008
Papers
71
H Index
42
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37085539
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Nat Commun
2023
37945900
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Nat Genet
2023
37085539
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Nat Commun
2023
37945900
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Nat Genet
2023
34615656
Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.
Cancer Discov
2022
34615656
Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.
Cancer Discov
2022
32822486
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
Neuro Oncol
2021
33762301
Notch Signaling between Cerebellar Granule Cell Progenitors.
eNeuro
2021
32822486
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
Neuro Oncol
2021
33428749
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma.
Neuro Oncol
2021
33762301
Notch Signaling between Cerebellar Granule Cell Progenitors.
eNeuro
2021
33428749
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma.
Neuro Oncol
2021
32703768
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies.
Cancer Discov
2020
32703768
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies.
Cancer Discov
2020
30326163
Integrated molecular characterization of IDH-mutant glioblastomas.
Neuropathol Appl Neurobiol
2019
31624378
Publisher Correction: Innate-like functions of natural killer T cell subsets result from highly divergent gene programs.
Nat Immunol
2019
31754034
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
Proc Natl Acad Sci U S A
2019
30595504
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.
Cancer Cell
2019
30326163
Integrated molecular characterization of IDH-mutant glioblastomas.
Neuropathol Appl Neurobiol
2019
30704404
InTAD: chromosome conformation guided analysis of enhancer target genes.
BMC Bioinformatics
2019
31477715
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Nat Commun
2019
31455674
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock.
Cancer Discov
2019
31076851
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
Acta Neuropathol
2019
30948495
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma.
J Exp Med
2019
31754034
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
Proc Natl Acad Sci U S A
2019
31455674
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock.
Cancer Discov
2019
31624378
Publisher Correction: Innate-like functions of natural killer T cell subsets result from highly divergent gene programs.
Nat Immunol
2019
31477715
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Nat Commun
2019
30948495
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma.
J Exp Med
2019
30704404
InTAD: chromosome conformation guided analysis of enhancer target genes.
BMC Bioinformatics
2019
31076851
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
Acta Neuropathol
2019
30595504
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.
Cancer Cell
2019
28990704
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
Brain Pathol
2018
28990704
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
Brain Pathol
2018
30030436
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma.
Nat Commun
2018
30349086
A biobank of patient-derived pediatric brain tumor models.
Nat Med
2018
30205043
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
Cancer Cell
2018
30006355
Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations.
Mol Cancer Res
2018
29909548
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
Acta Neuropathol
2018
30332335
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.
J Clin Oncol
2018
29489754
The landscape of genomic alterations across childhood cancers.
Nature
2018
29440261
Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming.
Genes Dev
2018
29753700
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Lancet Oncol
2018
29258295
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
Nature
2018
29435664
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.
Acta Neuropathol
2018
29551561
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma.
Dev Cell
2018
29539639
DNA methylation-based classification of central nervous system tumours.
Nature
2018
31105932
An accessible GenePattern notebook for the copy number variation analysis of Illumina Infinium DNA methylation arrays.
F1000Res
2018
29909548
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
Acta Neuropathol
2018
30205043
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
Cancer Cell
2018
1 - 50 of 142
Column Actions
Search
Recommended Authors
Li Chen
Indiana University School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Paul Guilhamon
The Hospital for Sick Children
Career Start Year
2013
Number of shared co-authors
29
Sriganesh Jammula
Early Cancer Institute, Hutchison Research Centre, University of Cambridge
Career Start Year
2013
Number of shared co-authors
3
Alex Murison
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2012
Number of shared co-authors
13
M Ryan Corces
Gladstone Institute of Neurological Disease
Career Start Year
2010
Number of shared co-authors
4
Pavlo Lutsik
Catholic University (KU) Leuven
Career Start Year
2010
Number of shared co-authors
14
Hui Shen
Van Andel Institute
Career Start Year
2010
Number of shared co-authors
3
Jeremy M Simon
University of North Carolina
Career Start Year
2010
Number of shared co-authors
2
Eleni M Tomazou
St. Anna Children's Cancer Research Institute (CCRI)
Career Start Year
2007
Number of shared co-authors
4
Yassen Assenov
German Cancer Research Center (DKFZ)
Career Start Year
2006
Number of shared co-authors
21
Altuna Akalin
Berlin Institute for Medical Systems Biology
Career Start Year
2006
Number of shared co-authors
1
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
2
Yin Shen
Wenzhou Medical University
Career Start Year
2005
Number of shared co-authors
0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
3
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year
2005
Number of shared co-authors
16
Richard Koche
Memorial Sloan Kettering Cancer Center
Career Start Year
2005
Number of shared co-authors
3
Gary C Hon
Cecil H. and Ida Green Center for Reproductive Biology Sciences
Career Start Year
2004
Number of shared co-authors
4
Houtan Noushmehr
Henry Ford Hospital
Career Start Year
2003
Number of shared co-authors
13
Ting Wang
Washington University School of Medicine
Career Start Year
2001
Number of shared co-authors
6
Peter J Park
Harvard Medical School
Career Start Year
2001
Number of shared co-authors
13
Benjamin P Berman
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Career Start Year
2000
Number of shared co-authors
1
Guo-Cheng Yuan
Dana-Farber Cancer Institute, Harvard School of Public Health
Career Start Year
2000
Number of shared co-authors
0
Kai Tan
University of Pennsylvania
Career Start Year
1999
Number of shared co-authors
0
Xiang Chen
St. Jude Children's Research Hospital
Career Start Year
1999
Number of shared co-authors
17
Martin Hirst
University of British Columbia
Career Start Year
1998
Number of shared co-authors
41
Bing Ren
Center for Epigenomics, University of California San Diego
Career Start Year
1995
Number of shared co-authors
13
Bradley E Bernstein
Broad Institute of MIT and Harvard
Career Start Year
1994
Number of shared co-authors
17
Joseph F Costello
University of California san francisco
Career Start Year
1991
Number of shared co-authors
31
Holger Heyn
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year
1988
Number of shared co-authors
2
Christoph Plass
German Cancer Research Center
Career Start Year
1982
Number of shared co-authors
47
row(s) 1 - 30 of 30
Collaborators
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
29
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
25
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
22
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
21
David Capper
Charite University Medicine Berlin
Co-authored papers
13
Anjana Rao
La Jolla Institute for Immunology
Co-authored papers
13
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers
12
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers
12
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
11
Andreas von Deimling
Co-authored papers
10
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
10
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers
9
Tanvi Sharma
Boston Children's Hospital
Co-authored papers
9
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers
9
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers
8
Serap Erkek
Co-authored papers
8
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
7
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
7
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers
7
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers
7
Marc Zapatka
Co-authored papers
7
Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
7
Konstantin Okonechnikov
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
7
Arie Perry
University of California san francisco
Co-authored papers
6
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers
6
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
6
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers
6
Ralf Herwig
Max Planck Institute for Molecular Genetics
Co-authored papers
6
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
6
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
6
1 - 30